Search

Search Constraints

You searched for: Author/Creator Gisslinger, Heinz

Search Results

1. A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial. (28th March 2019)

4. Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations. Issue 4 (April 2022)

5. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality. Issue 23 (28th September 2015)

8. Decanucleotide insertion polymorphism of F7 significantly influences the risk of thrombosis in patients with essential thrombocythemia. (23rd April 2014)

10. Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 109/L to <100 × 109/L) at baseline: the final analysis of EXPAND. (September 2022)